Rollins Total Revenue decreased by 0.7% to $906.42M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $822.50M to $906.42M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 11.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $638.20M | $650.20M | $600.34M | $590.68M | $714.05M | $729.70M | $661.39M | $658.02M | $820.75M | $840.43M | $754.09M | $748.35M | $891.92M | $916.27M | $832.17M | $822.50M | $999.53M | $1.03B | $912.91M | $906.42M |
| QoQ Change | — | +1.9% | -7.7% | -1.6% | +20.9% | +2.2% | -9.4% | -0.5% | +24.7% | +2.4% | -10.3% | -0.8% | +19.2% | +2.7% | -9.2% | -1.2% | +21.5% | +2.7% | -11.0% | -0.7% |
| YoY Change | — | — | — | — | +11.9% | +12.2% | +10.2% | +11.4% | +14.9% | +15.2% | +14.0% | +13.7% | +8.7% | +9.0% | +10.4% | +9.9% | +12.1% | +12.0% | +9.7% | +10.2% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Residential revenues | $408.41M | $428.29M | $369.06M | $356.31M | $455.67M | $476.27M | $405.00M | $389.50M |
| Commercial revenues | $287.77M | $299.63M | $280.45M | $284.36M | $320.49M | $334.96M | $304.93M | $311.73M |
| Termite and ancillary revenues | — | — | — | — | $211.86M | $204.67M | $192.89M | $195.42M |
| Franchise revenues | $4.45M | $4.28M | $4.25M | $3.77M | $3.91M | $4.31M | $4.04M | $3.65M |
| Other revenues | — | — | $5.99M | — | — | — | $6.06M | — |
| Termite completions, bait monitoring, & renewals | $186.02M | $177.67M | $172.43M | $172.13M | — | — | — | — |
| Total | $891.92M | $916.27M | $832.17M | $822.50M | $999.53M | $1.03B | $912.91M | $906.42M |
Commercial revenue, Residential revenue, Termite Completions Bait Monitoring Renewals, Termite completions, bait monitoring, & renewals were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $822.50M | $999.53M | $1.03B | $912.91M | $906.42M |
| Total | $822.50M | $999.53M | $1.03B | $912.91M | $906.42M |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Other countries | $64.08M | $66.02M | $60.75M | $59.15M | $71.85M | $73.43M | $65.30M | $66.55M |
| Total | $891.92M | $916.27M | $832.17M | $822.50M | $999.53M | $1.03B | $912.91M | $906.42M |